Related references
Note: Only part of the references are listed.Oncogenic Role of PVT1 and Therapeutic Implications
Onayemi Titilayo Onagoruwa et al.
FRONTIERS IN ONCOLOGY (2020)
Long Noncoding RNA PVT1 as a Novel Predictor of Metastasis, Clinicopathological Characteristics and Prognosis in Human Cancers: a Meta-Analysis
Congmin Liu et al.
PATHOLOGY & ONCOLOGY RESEARCH (2019)
The role of long non-coding RNAs in multiple myeloma
Yu-Shan Cui et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2019)
Regulatory Mechanisms and Clinical Applications of the Long Non-coding RNA PVT1 in Cancer Treatment
Meng-Yuan Li et al.
FRONTIERS IN ONCOLOGY (2019)
Chemoresistance Mediated by ceRNA Networks Associated With the PVT1 Locus
Olorunseun O. Ogunwobi et al.
FRONTIERS IN ONCOLOGY (2019)
Long Non-Coding RNAs in Multiple Myeloma
Romana Butova et al.
NON-CODING RNA (2019)
Long non-coding RNA PVT1 as a novel candidate for targeted therapy in hematologic malignancies
Mohammad Houshmand et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2018)
Long-Term Follow-up of Monoclonal Gammopathy of Undetermined Significance
Robert A. Kyle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Prognostic values of long noncoding RNA PVT1 in various carcinomas: An updated systematic review and meta-analysis
Meizhu Xiao et al.
CELL PROLIFERATION (2018)
Down-regulation of miR-203a by lncRNA PVT1 in multiple myeloma promotes cell proliferation
Man Yang et al.
ARCHIVES OF MEDICAL SCIENCE (2018)
Role of the long non-coding RNA PVT1 in the dysregulation of the ceRNA-ceRNA network in human breast cancer
Federica Conte et al.
PLOS ONE (2017)
lncRNA PVT1 in cancer: A review and meta-analysis
Dapeng Lu et al.
CLINICA CHIMICA ACTA (2017)
Long non-coding RNA MALAT1 is an inducible stress response gene associated with extramedullary spread and poor prognosis of multiple myeloma
Hiroshi Handa et al.
BRITISH JOURNAL OF HAEMATOLOGY (2017)
The landscape of long noncoding RNAs in the human transcriptome
Matthew K. Iyer et al.
NATURE GENETICS (2015)
PVT1: A Rising Star among Oncogenic Long Noncoding RNAs
Teresa Colombo et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Long noncoding RNAs: a potential novel class of cancer biomarkers
Aliaksandr A. Yarmishyn et al.
FRONTIERS IN GENETICS (2015)
Expanding the functional role of long noncoding RNAs
Per Johnsson et al.
CELL RESEARCH (2014)
PVT1 dependence in cancer with MYC copy-number increase
Yuen-Yi Tseng et al.
NATURE (2014)
Selective Inhibition of Tumor Oncogenes by Disruption of Super-Enhancers
Jakob Loven et al.
CELL (2013)
Super-Enhancers in the Control of Cell Identity and Disease
Denes Hnisz et al.
CELL (2013)
Molecular pathogenesis of multiple myeloma: basic and clinical updates
Marta Chesi et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2013)
Frequent PVT1 Rearrangement and Novel Chimeric Genes PVT1-NBEA and PVT1-WWOX Occur in Multiple Myeloma with 8q24 Abnormality
Hisao Nagoshi et al.
CANCER RESEARCH (2012)
Transcriptional Amplification in Tumor Cells with Elevated c-Myc
Charles Y. Lin et al.
CELL (2012)
Landscape of transcription in human cells
Sarah Djebali et al.
NATURE (2012)
BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
Jake E. Delmore et al.
CELL (2011)
MEDICAL PROGRESS Multiple Myeloma
Antonio Palumbo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
The PVT-1 oncogene is a myc protein target is overexpressed in transformed cells
Letizia Carramusa et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2007)
Amplification of PVT1 contributes to the pathophysiology of ovarian and breast cancer
Yinghui Guan et al.
CLINICAL CANCER RESEARCH (2007)
Low molecular weight inhibitors of Myc-Max interaction and function
XY Yin et al.
ONCOGENE (2003)
Share Paper
